Assessment of the Potential Interactions Between Cocaine and GBR 12909 - 1
NCT00051896 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 24
Last updated 2017-01-11
Summary
The purpose of this study is to assess the potential interactions between iv cocaine and GBR 12909.
Conditions
- Cocaine-Related Disorders
Interventions
- DRUG
-
GBR 12909
Sponsors & Collaborators
-
National Institute on Drug Abuse (NIDA)
lead NIH
Principal Investigators
-
Louis Cantilena, M.D. · Uniformed Services University of Health Science
Study Design
- Purpose
- TREATMENT
- Masking
- DOUBLE
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2002-08-31
Countries
- United States
Study Locations
More Related Trials
-
Study to Assess Potential Interactions Between Intravenous Cocaine and Oral Lorcaserin
NCT02393599 ·Status: COMPLETED ·Phase: PHASE1
-
Drug Interaction and Self Administration Studies of Compounds for Cocaine Use Disorder
NCT02537873 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Assess Safety, Tolerability, and Interactions of Cocaine and Oral AFQ056
NCT04771143 ·Status: WITHDRAWN ·Phase: PHASE1
-
Interactions Between Cocaine and Ethanol and Disulfiram - 1
NCT00094289 ·Status: UNKNOWN ·Phase: PHASE1
-
Improving Learning-based Treatment of Cocaine Dependence With Medication
NCT01526538 ·Status: COMPLETED ·Phase: PHASE2
-
Use of Donepezil for Treatment of Cocaine Dependence
NCT00467389 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Modafinil as a Cocaine Treatment Medication and Interactions With Cocaine - 1
NCT00033046 ·Status: UNKNOWN ·Phase: PHASE1
-
Behavioral Effects of Drugs: Inpatient (35)
NCT03519022 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Development of Human Laboratory Study Model of Cocaine Relapse Prevention. - 1
NCT00040066 ·Status: UNKNOWN ·Phase: PHASE1
-
Glutaminergic Agents for Cocaine Abuse - 5
NCT00000280 ·Status: COMPLETED ·Phase: PHASE1
-
The Effect of Yohimbine on Cocaine Cue Reactivity
NCT00535002 ·Status: COMPLETED ·Phase: PHASE2
-
Metabolic Effects of Cocaine
NCT00451230 ·Status: COMPLETED ·Phase: NA
-
Impact of a Non-Drug Choice on Cocaine Reinforcement
NCT01906346 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Effects of Carvedilol on Cocaine Use in Humans - 11
NCT00000294 ·Status: COMPLETED ·Phase: PHASE2
-
Cocaine and Zolmitriptan
NCT05019430 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Cognitive Enhancement and Relapse Prevention in Cocaine Addiction
NCT01067846 ·Status: COMPLETED ·Phase: NA
-
A Novel Anti-Obesity Drug Combination as a Pharmacotherapy for Cocaine Dependence
NCT01739192 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Cocaine Withdrawal and Pharmacotherapy Response
NCT00566969 ·Status: COMPLETED ·Phase: NA
-
Behavioral and Physiological Effects of Cocaine in Cocaine-dependent Participants Treated With Levodopa in Combination With Carbidopa and Entacapone (LCE)
NCT01437293 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Investigate the Interaction Between TMP-301 and Cocaine.
NCT06648668 ·Status: COMPLETED ·Phase: PHASE1
-
Development of Human Laboratory Study Model of Cocaine Relapse Prevention II - 1
NCT00094315 ·Status: UNKNOWN ·Phase: PHASE1
-
Interactions Between Intravenous Cocaine and Acetazolamide or Quinine
NCT01851473 ·Status: COMPLETED ·Phase: PHASE1
-
Multiple Ascending Dose Study of TMP-301 in Healthy Subjects
NCT06025396 ·Status: COMPLETED ·Phase: PHASE1
-
Cocaine-Methylphendidate Interaction Study - 4
NCT00015067 ·Status: COMPLETED ·Phase: PHASE1
-
Carbamazepine Treatment for Cocaine Dependence - 5
NCT00000191 ·Status: COMPLETED ·Phase: PHASE2